Constitutive gp130 activation rapidly accelerates the transformation of human hepatocytes via an impaired oxidative stress response
Metrics: PDF 1106 views | HTML 1635 views | ?
Denise Heim1,*, Ines Gil-Ibanez1,*, Johannes Herden1, Ann Christin Parplys2, Kerstin Borgmann2, Dirk Schmidt-Arras3, Ansgar W. Lohse1, Stefan Rose-John3, Henning Wege1
1Department of Gastroenterology and Hepatology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
2Laboratory of Radiobiology and Experimental Radiooncology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
3Institute of Biochemistry, Christian-Albrechts-Universität zu Kiel, 24098 Kiel, Germany
*These authors have contributed equally to this work
Henning Wege, email: firstname.lastname@example.org
Keywords: interleukin 6, glycoprotein 130, reactive oxygen species, oxidative stress response, hepatocyte transformation
Received: March 01, 2016 Accepted: July 09, 2016 Published: July 30, 2016
Pro-inflammatory signaling pathways, especially interleukin 6 (IL-6), and reactive oxygen species (ROS) promote carcinogenesis in the liver. In order to elucidate the underlying oncogenic mechanism, we activated the IL-6 signal transducer glycoprotein 130 (gp130) via stable expression of a constitutively active gp130 construct (L-gp130) in untransformed telomerase-immortalized human fetal hepatocytes (FH-hTERT). As known from hepatocellular adenomas, forced gp130 activation alone was not sufficient to induce malignant transformation. However, additional challenge of FH-hTERT L-gp130 clones with oxidative stress resulted in 2- to 3-fold higher ROS levels and up to 6-fold more DNA-double strand breaks (DSB). Despite increased DNA damage, ROS-challenged FH-hTERT L-gp130 clones displayed an enhanced proliferation and rapidly developed colony growth capabilities in soft agar. As driving gp130-mediated oncogenic mechanism, we detected a decreased expression of antioxidant genes, in particular glutathione peroxidase 3 and apolipoprotein E, and an absence of P21 upregulation following ROS-conferred induction of DSB. In summary, an impaired oxidative stress response in hepatocytes with gp130 gain-of-function mutations, as detected in dysplastic intrahepatic nodules and hepatocellular adenomas, is one of the central oncogenic mechanisms in chronic liver inflammation.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.